1989
DOI: 10.1111/j.1365-2044.1989.tb11280.x
|View full text |Cite
|
Sign up to set email alerts
|

Neostigmine after spontaneous recovery from neuromuscular blockade

Abstract: SummaryThe effect of neostigmine on neuromuscular function was examined after spontaneous recovery from an atracurium-induced neuromuscular blockade, which reached a train-of-four ratio of either 0.5 or 0.9. Two doses ofneostigmine 2.5 mg were given 5 minutes apart.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
10
0

Year Published

1993
1993
2020
2020

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 52 publications
(12 citation statements)
references
References 24 publications
1
10
0
Order By: Relevance
“…Another study reported similar reintroduction of neuromuscular blockade with a second dose of neostigmine (2.5 mg) after the first dose at 1 hour after administration of vecuronium 51. A later study also indicated that a second dose of neostigmine 2.5 mg diminished tetanic height and increased tetanic fade after the first dose (2.5 mg) administered for reversal of atracurium-induced neuromuscular blockade, which might adversely affect neuromuscular function 24. It was found that some patients (eight in 60) who were given 0.04 mg/kg neostigmine at 2–4 hours after a single dose of vecuronium (0.1 mg/kg) had decreased TOFR after the administration, and the TOFR of those patients had recovered to ≥0.9 at the time of reversal, although this effect was short-lived (only 10–20 minutes) 24,52.…”
Section: Administration For Neuromuscular Blockade Reversalmentioning
confidence: 83%
“…Another study reported similar reintroduction of neuromuscular blockade with a second dose of neostigmine (2.5 mg) after the first dose at 1 hour after administration of vecuronium 51. A later study also indicated that a second dose of neostigmine 2.5 mg diminished tetanic height and increased tetanic fade after the first dose (2.5 mg) administered for reversal of atracurium-induced neuromuscular blockade, which might adversely affect neuromuscular function 24. It was found that some patients (eight in 60) who were given 0.04 mg/kg neostigmine at 2–4 hours after a single dose of vecuronium (0.1 mg/kg) had decreased TOFR after the administration, and the TOFR of those patients had recovered to ≥0.9 at the time of reversal, although this effect was short-lived (only 10–20 minutes) 24,52.…”
Section: Administration For Neuromuscular Blockade Reversalmentioning
confidence: 83%
“…The upper limit of anticholinesterase dosage is limited by a "ceiling effect" at high doses and deep levels of block 63 and potential adverse effects on neuromuscular function when high or repeated doses are used. 64 The factors enumerated above influence the degree of neuromuscular blockade at which reversal should be attempted. With respect to safe clinical practice, certain conclusions can be drawn.…”
Section: Incidence and Aetiologymentioning
confidence: 99%
“…Anticholinesterase agents such as neostigmine, posses neuromuscular blocking properties in the absence of previously administered muscle relaxants [8,9]. Neostigmine, in a small number of patients, has been shown to increase tetanic fade hence a considerable degree of spontaneous recovery from a muscle relaxant has occurred.…”
Section: Response To Querymentioning
confidence: 99%
“…This remains as one of the most common but undetected occurrence in early postoperative period [6][7][8]. Also, it has been shown that neuromuscular blockade can persist for up to 4 hours following even a single dose of Vecuronium (0.1mg/kg) [9].…”
mentioning
confidence: 99%